zitac vet 200mg tablety pro psy 200 mg tableta
intervet international, b.v. - cimetidin - tableta - 200mg - antagonisté h2-receptorů - psi
famosan 10mg potahovaná tableta
pro.med.cs praha a.s. array - 9064 famotidin - potahovaná tableta - 10mg - famotidin
famosan 20mg potahovaná tableta
pro.med.cs praha a.s. array - 9064 famotidin - potahovaná tableta - 20mg - famotidin
famosan 40mg potahovaná tableta
pro.med.cs praha a.s. array - 9064 famotidin - potahovaná tableta - 40mg - famotidin
quamatel 20mg prášek a rozpouštědlo pro injekční/infuzní roztok
gedeon richter plc., budapešť array - 9064 famotidin - prášek a rozpouštědlo pro injekční/infuzní roztok - 20mg - famotidin
ranisan 150mg potahovaná tableta
pro.med.cs praha a.s. ČeskÁ republika - 4191 ranitidin-hydrochlorid - potahovaná tableta - 150mg - ranitidin
ranisan 75mg potahovaná tableta
pro.med.cs praha a.s. ČeskÁ republika - 4191 ranitidin-hydrochlorid - potahovaná tableta - 75mg - ranitidin
zitac vet 100 mg tablety pro psy 100 mg tableta
intervet international, b.v. - cimetidin - tableta - 100mg - lÉkŮ pro ŽaludeČnÍho vŘedu a refluxnÍ choroba jÍcnu (gord) - psi
pregabalin zentiva
zentiva, k.s. - pregabalin - anxiety disorders; epilepsy - antiepileptika, - neuropathic pain , pregabalin zentiva is indicated for the treatment of peripheral and central neuropathic pain in adults. , epilepsy , pregabalin zentiva is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. , generalised anxiety disorder , pregabalin zentiva is indicated for the treatment of generalised anxiety disorder (gad) in adults.
rivaroxaban viatris (previously rivaroxaban mylan)
mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotické činidla - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers. rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.